Revolution Medicines (NASDAQ:RVMD – Free Report) had its target price lowered by JPMorgan Chase & Co. from $47.00 to $39.00 in a research note published on Tuesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other brokerages also recently issued reports on RVMD. Oppenheimer increased their price […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) announced its earnings results on Monday. The company reported ($0.99) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.01) by $0.02, Briefing.com reports. Revolution Medicines had a negative return on equity of 38.92% and a negative net margin of 1,003.36%. During the same period […]
09.11.2023 - Acquisition Expected to Add Approximately $1.1 Billion in Net Cash to Revolution Medicines’ Balance Sheet, Supporting Late-Stage Development of RAS(ON) Inhibitor Investigational Drugs Sandra Horning, M.D., Joins Revolution Medicines Board of . Seite 1
Revolution Medicines (NASDAQ:RVMD) Posts Earnings Results, Beats Expectations By $0 02 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.